Management Team

Prof. Eli Hazum

Chief Executive Officer

Eli brings diverse expertise from both the healthcare industry and academia. He has been a general partner with Medica VC since 1995. prior to joining Medica, Eli spent 5 years at Glaxo Inc. at the Research Triangle Park, NC, as Head of the Department of Receptor Research and Metabolic Diseases, and as a member of the Corporate Committee for New Technology Identification, worldwide in osteoporosis. Upon returning to Israel, Eli served in various executive research and development positions at Biotechnology General Corp. (Savient) and as VP R&D at Peptor Ltd. Over the last 15 years Eli has taken leadership roles within Medica portfolio companies including interim CEO for Collgard Biopharmaceuticals and Ester Neurosciences, where he was responsible for executing Ester’s acquisition by Amarin Pharmaceuticals.

Eli received his Ph.D. degree from the Weizmann Institute of Science in 1978 based on research in the field of hormone biochemistry, and has an executive MBA from Humberside University in the UK. He is the author of more than 100 scientific publications and patents in various areas of drug development.

Dr. Sigal Aviel

Chief Operating Officer

Sigal brings 15 years of managerial experience in the Biotech industry. Prior to joining PainReform Sigal held the position of Chief R&D Officer at MediWound, a company specializing in deep burns and chronic wound care, where she was responsible for product development from early stages to final product approval by regulatory authorities. Previously she served as a VP of clinical and regulatory affairs at Biokine LTD focusing on cancer therapy.  Formerly she directed both platform and project development at Protalix Biotherapeutics while managing a large group of scientists on projects ranging from autoimmune diseases to chemical warfare and genetic diseases.

Sigal holds a PhD in Immunology and Microbiology from Duke University Medical School as well as an executive MBA degree from the Kellogg school of business at NW University. She did her postdoctoral work with Nobel laureate Prof. Aaron Ciechanover.

Mr. Lihu avitov

VP business development

Lihu brings 17 years of experience in healthcare management. Previously Mr. Avitov  served 3.5 years as Angioslide CEO between 2011-2015. Prior to Angioslide he served as an EVP at XT Investments ech, one of Israel’s leading private equity firms, heading the healthcare team. Prior to that, he served as CEO of Naiot Venture Accelerator, and as General Manager of Rimlon, a medical device company in the orthopedics field. At XT and Naiot he led various investments in innovative healthcare technologies and played an active role in their day-to-day management. In 2007 Mr. Avitov co-founded PainReform. Mr. Avitov holds a bachelor's degree in Economics and Management, and a master's degree from the Department of Industrial Engineering and Management at the Technion – Israel Institute of Technology in Haifa, Israel.